PubMed

Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.

Ozkiris A, Erkiliç K, Koç A, Mistik S.

Br J Ophthalmol. 2007 Jan;91(1):69-73. Epub 2006 Sep 14.PMID: 16973667 [PubMed - indexed for MEDLINE]Related articles

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.

Diabetes Atorvastin Lipid Intervention (DALI) Study Group.

Diabetes Care. 2001 Aug;24(8):1335-41.PMID: 11473066 [PubMed - indexed for MEDLINE]Related articlesFree article

[Assessment of blood flow in the ocular circulation in type 2 diabetes patients with Color Doppler imaging]

Kraśnicki P, Mariak Z, Ustymowicz A, Proniewska-Skretek E.

Klin Oczna. 2006;108(7-9):294-8. Polish. PMID: 17290827 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.

Pontrelli L, Parris W, Adeli K, Cheung RC.

Metabolism. 2002 Mar;51(3):334-42.PMID: 11887170 [PubMed - indexed for MEDLINE]Related articles

Ocular blood flow velocity determined by color Doppler imaging in diabetic retinopathy.

Gracner T.

Ophthalmologica. 2004 Jul-Aug;218(4):237-42.PMID: 15258411 [PubMed - indexed for MEDLINE]Related articles

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313.PMID: 19167589 [PubMed - indexed for MEDLINE]Related articles

Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.

Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N.

Drugs R D. 2008;9(4):243-50.PMID: 18588355 [PubMed - indexed for MEDLINE]Related articles

Effects of pars plana vitrectomy on retrobulbar haemodynamics in diabetic retinopathy.

Sullu Y, Hamidova R, Beden U, Yakupov K, Canbaz S, Danaci M.

Clin Experiment Ophthalmol. 2005 Jun;33(3):246-51.PMID: 15932527 [PubMed - indexed for MEDLINE]Related articles

Colour Doppler imaging of the ocular circulation in diabetic retinopathy.

MacKinnon JR, McKillop G, O'Brien C, Swa K, Butt Z, Nelson P.

Acta Ophthalmol Scand. 2000 Aug;78(4):386-9.PMID: 10990037 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.PMID: 12534315 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Keilson LM, Brown WV, Miller VT, Shurzinske LJ, Black DM.

JAMA. 1996 Jan 10;275(2):128-33.PMID: 8531308 [PubMed - indexed for MEDLINE]Related articles

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.

Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D.

Diabetes Care. 2006 Jun;29(6):1220-6.PMID: 16731999 [PubMed - indexed for MEDLINE]Related articlesFree article

Hemodynamic alterations in diabetic retinopathy.

Güven D, Ozdemir H, Hasanreisoglu B.

Ophthalmology. 1996 Aug;103(8):1245-9.PMID: 8764795 [PubMed - indexed for MEDLINE]Related articles

Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.

Diepeveen SH, Verhoeven GW, Van Der Palen J, Dikkeschei LD, Van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.

J Intern Med. 2005 May;257(5):438-45.PMID: 15836660 [PubMed - indexed for MEDLINE]Related articles

Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.

Wu CC, Sy R, Tanphaichitr V, Hin AT, Suyono S, Lee YT.

J Formos Med Assoc. 2002 Jul;101(7):478-87.PMID: 12353340 [PubMed - indexed for MEDLINE]Related articles

Ocular arterial flow hemodynamics in patients with diabetes mellitus.

Arai T, Numata K, Tanaka K, Kiba T, Kawasaki S, Saito T, Satoh S, Sekihara H.

J Ultrasound Med. 1998 Nov;17(11):675-81.PMID: 9805302 [PubMed - indexed for MEDLINE]Related articles

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101.PMID: 18640465 [PubMed - indexed for MEDLINE]Related articles

Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension.

Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, Kingwell BA.

J Am Coll Cardiol. 2002 Mar 20;39(6):1020-5.PMID: 11897445 [PubMed - indexed for MEDLINE]Related articles

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.

Frost RJ, Otto C, Geiss HC, Schwandt P, Parhofer KG.

Am J Cardiol. 2001 Jan 1;87(1):44-8.PMID: 11137832 [PubMed - indexed for MEDLINE]Related articles

Correlation between higher blood flow velocity in the central retinal vein than in the central retinal artery and severity of nonproliferative diabetic retinopathy.

Fujioka S, Karashima K, Nishikawa N, Saito Y.

Jpn J Ophthalmol. 2006 Jul-Aug;50(4):312-7.PMID: 16897214 [PubMed - indexed for MEDLINE]Related articles